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   Thyroid tissues obtained from 360 cases by means of operation were 
classified pathohistologically into normal thyroid, benign thyroid diseases 
and malignant thyroid tumors and stained by FEULGEN' S method. Sex 
chromatins of follicular epithelial cells (tumor cells) and interstitial cells 
were counted for each case and incidence of sex chromatin was compared 
among those groups. 
   The specimens used in the present study were all obtained from female 
subjects ranging in age from 15 to 77. In most cases of normal thyroid and 
benign thyroid diseases, incidence of sex chromatin showed more than 30%. 
However, in 2/3 of the cases of so-called malignant adenoma where capsular 
invasion was verified, incidence of sex chromatin was less than 30% in the 
very region of the capsular invasion but over 30% in the uninvaded region. 
   In the cases of thyroid cancer, incidence of sex chromatin was less 
than 30%. It was higher in papillary adenocarcinoma and follicular adeno-
carcinoma than undifferentiated carcinoma. There was hardly noted any 
difference in incidence of sex chromatin between the primary lesion and the 
metastasized lesion in the lymph node. 
   Variation in incidence of sex chromatin by age was not recognized in the 
disease groups but only in the group of normal thyroid.
                  INTRODUCTION 
   In 1959, BARR and BERTRAMO found nucleoli measuring 1,a in size 
in the nucleus of the hypoglossal nerve cells of the cat. Since the 
nucleoli were found only in the female cat, they considered these 
nucleoli related to sex and named them as sex chromatins. 
   Sex chromatins are generally basophile and show strong positive 
reaction to FEULGEN'S 'staining. They are hemispheric or flat in shape
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and are either attached to the inside of the nuclear membrane of free 
within the nuclear substance. 
   Sex chromatins have been verified in the epithelial cells of the 
oral cavity, vagina and urinary tract and in various tissues of the 
skin, leukocyte and others of animals and man. 
   Sex chromatins are frequently found in the cell nucleus of females 
and rarely in the cell nucleus of males. In this respect, sex chroma-
tins are used clinically for sex distinction particularly , for intersex and 
are considered indispensable for sex determination of ndividuals . 
   The idea of sex determination has been introduced,: to character of 
tumor by examination of the rate of content of sex chromatins in the 
tumor cells. However, as HUNTER and LENNOx9) observed in teratoma 
in 1954, the sex of the host and the sex determined by the incidence 
of sex chromatin are not always identical. 
   Concerning sex chromatin in tumor, many studies have been made 
since then by TAVARES24> , CRUICKSHANK3>, SOHVAL22) , EMERY and 
MCMILLAN5), LEHMAN11), BARR and MOORE2., HIENZ and EHLER8) , 
ZANNELLA28) , GRAF6), MYERSI %. and other investigators. As the result, 
it has been clarified that the sex of the host of tumor and the sex 
determined from the incidence of sex chromatin in tumor are generally 
identical but in tumors of endocrine organs such as pheochromocyto-
ma, mammary tumor and prostatic tumor, they are not identical with 
a fairly high frequency. 
   Furthermore, studies are being made to see whether or not 
incidence of sex chromatin is useful as an index to determine the 
adaptability of hormone therapy for tumors of endocrine organs parti-
cularly for mammary tumor and prostatic tumor. It has been conside-
red to be available as a means to estimate the degree of the dependency 
of cancer cells on hormone. In order to examine if incidence of sex 
chromatin is a useful index of horomone therapy for thyroid tumor, the 
author counted sex chromatins in the thyroid in various conditions, 
and studied the relationship between incidence of sex chromatin in 
tumor cells and the nature (malignancy or benignity) of tumor.
             MATERIALS AND METHODS 
   The materials used in the present study were specimens of thyroid 
tissue obtained from 360 cases by operation at the Second Department 
of Surgery of NAGASAKI UNIVERSITY HOSPITAL and the NOGUCHI HOSPITAL 
in BEPPU CITY during the four-year period from 1965 to 1968. Patho-
histological diagnosis was established for all these cases. 
   These 360 cases consisted of 36 cases of normal thyroid, 60 cases 
of diffuse goiter with hyperthyroidism, 16 cases of chronic thyroiditis, 
8 cases of adenomatous goiter, 60 cases of adenoma, 60 cases of
so-called malignant adenoma and 
120 cases of thyroid cancer. For 
these cases, pathohistological 
diagnosis was first established 
upon HE stain and incidence of 
sex chromatin was calculated 
with sections of FEULGEN'S stain. 
(Table 1) 
   For calculation of sex chro-
matins, 1000x oil immersion 
microscopy was used and 100 
cell nuclei each at three different 
areas , , of a section, totalling 300 
cell nuclei, were examined for 
the presence of sex chromatin 
and the percentage of sex chro-
           Table I . 
Incidence o` Sex Chromatin in Various 
Thyroid Diseaes (360 Cases)
Pathological Diagnosis No. of Range Mean                  Cases (%) (%) 
Normal Thyroid Gland 36 35-80 50 
Chronic Thyroiditis 16 26-46 34 
Adenomatous Goiter 8 29-52 41 
Diffuse Goiter with 60 31-63 45 
     Hyperthyroidism 
Adenoma 60 29-78 44 
Malignant Adenoma 60 11-68 30 
Thyroid Cancer 120 5-42 21
matin positive cells was used as incidence of sex chromatin. 
   At the time of microscopic examination, those cells which were 
clearly visible and whose nuclei were not overlapped with. others were 
selected as the objects of calculation. Those nucleoli measuring 1 V 
in size attached to the nuclear membrane and shaped somewhat 
rounded or flattened hemispheric were calculated as chromatins ; those 
which were free in the nucleolus and nuclear substance, vaguely 
demarcated or irregular-shaped were excluded from calculation. (Photo 2)
Photo. 2 Many Sex Chromatin are present in the follicular epithelial cells in 
           a -patient s ith "adenoma of thyroid gland. (Feulgen's stain, x 1000)
          A picture on the upper right side is that in high po-.2 er, Sex Chro-
           matins are rounded or hemispheric in shape and tightly attached to 
           the unclear menbrane. (x 1400, Feulgen's stain)
   The calculation of such sex chromatins was conducted , separately 
for follicular epithelial cells (tumor cells) and interstitial- cells.
RESULTS
    In the 36 cases of normal 
thyroid, the function and histo-
logical findings were normal and 
the specimens were obtained 
mostly by incisional biopsy. The 
incidence of sex chromatin in the 
follicular epithelial cells ranged 
from 35% to 80%, the mean 
value being 50%. The incidence 
in the interstitial cells was bet-
ween 29% and 57% with the 
mean of 39%. Thus the former 
was higher than the latter show-
ing statistically significant dif-
ference (P=0.05). (Fig. 1) 
   As to the relationship bet-
ween age and incidence of sex 
chromatin in the cases of normal 
thyroid, the mean incidence in 
the follicular epithelial cells was 
66.1% in teenage, 59% in 20's, 
54% in 30's, 42.5% in 40's, 44.2 
% in 50's and 46.2% in 60's or 
more. The incidence of sex 
chromatin gradually decreased 
as the age advanced up to 40's 
and thereafter remained almost 
constant ranging from 40% to 45 
%. On the other hand, the 
mean incidence of sex chromatin 
in the interstitial cells of normal 
thyroid was 41.5% in teenage, 
59% in 20's, 42% in 30's, 37% 
in 40's, 42% in 50's and 40% in 
60's or more. Whereas nearly 
60% was indicated for 20's, the 
values for other age groups were 
almost constant, being approxi-
mately 40%. (Fig. 2)
Fig. 1. Incidence of Sex Chromatin in 
       Normal Thyroid Gland
1: Follicular Epithelial Cells 
2: Interstitial Cells
   In the 60 cases of diffuse goiter with hyperthyroidism, the inci-
dence of sex chromatin in the follicular epithelial cells ranged from 
31% to 63%, the mean value being 45%. The incidence in the 
interstitial cells ranged from 28% to 60% with the mean of 39%. No 
significant difference was noted between the two incidences nor was 
observed any specific change due to age. (Fig. 3) 
   The incidence of sex chromatin in the 16 cases of chronic thyroi-
ditis was calculated only in the follicular epithelial cells and it ranged 
from 26% to 46% with the mean of W/o. 
   The incidence of sex chromatin in the 8 cases of adenomatous 
goiter was calculated in the follicular epithelial cells and it ranged 
from 29% to 52% with the mean of 41%. Calculation in the interstitial 
cells was not performed. (Table 2)
Fig. 2. Variation in Incidence of Sex Chromatin by Age
Fig. 3. Incidence of Sex Chromatin in 
       Diffuse Goiter with Hyperthy-
       roidism
Fig. 4 Incidence of Sex Chromatin in Adenoma
1: Follicular Cells 
2:Interstitial Cells
1:Tumor Cells 
2: Interstitial Cells 
3 : Follicular Epithelial 
 Cells of Thyroid Tissue 
  Other than Adenoma
   In the 60 cases of adenoma 
of the thyroid, sex chromatins 
were calculated in three constitu-
ent parts of thyroid, namely, 
tumor cells, interstitial cells of 
the capsule of adenoma and folli-
cular epithelial cells of normal 
thyroid tissue other than adeno-
ma, and the incidence was com-
pared among the three parts.
               Table 2. 
 Tissue Type and Sex Chromatin in Thyroid 
  Cancer 
    Tissue Type No. of Range Mean                    Cases (/ o) (/o) 
Papillary Adenocarcioma 63 53-32 19 
Follicular Aeenocarcinoma 49 10-42 22 
Undifferentiated Carcinoma 8 10-20 15
The incidence in the tumor cells of adenoma ranged from 29% to 78% 
but in most of the cases from 40% to 60% indicating the mean value 
of 44%. The incidence of sex chromatin in the interstitial cells of the 
capsule of adenoma showed the mean value of 39% ranging from 28% 
to 65%. In the follicular epithelial cells of normal thyroid tissue 
other than adenoma, the mean value was 49% ranging from 34% to 
80%. No significant difference (P= 0.05) was noted between the 
incidence of sex chromatin in the tumor cells of adenoma and that in 
the follicular epithelial cells of the normal part. However, the inci-
dence in the interstitial cells of the capsule was significantly lower 
(P=0.05) than the incidence in the other two parts. (Fig. 4)
Fig. 5. Schema of So-Called Malignant Adenoma
1 : Tumor Cells with Capsular Invasion 
2 Tumor Cells without Capsular Invasion 
3 : Follicular Epithelial Cells of Normal Parts outside the Capsule
   The author has heretofore described the ranges and mean values 
of incidence of sex chromatin in the follicular epithelial cells and 
interstitial cells of the normal thyroid and the thyroid tissue of benign
Fig. 6. Incidence of Sex Chromatin in So-
        Called Malignant A- enoma
1 : Tumor Cells with Capsular 
  Invasion 
2 : Tumor Cells without 
  Capsular Invasion 
3 : Follicular Epithelial Cells 
 of Normal Parts outside the 
 Capsule
thyroid diseases such as 
diffuse goiter with hyper-
thyroidism, chronic thy-
roiditis, adenoma and 
adenomatous goiter. The 
mean value of the inci-
dence of sex chromatin in 
the follicular epithelial 
cells was 50% in normal 
thyroid, 45% in diffuse 
goiter with hyperthyroidi-
sm, 44% in adenoma, 41 
% in adenomatous goiter 
and 34% in chronic thy-
roiditis; the value was 
the highest in the normal 
thyroid and the lawest in 
chrodic thyroiditis. The 
relationship between the 
age and incidence of sex 
chromatin is as stated 
previously in this paper. 
In the. follicular epithelial 
cells of normal thyroid, 
the incidence of sex chro-
matin gradually decreased 
as the age advanced but 
afer age 40 it remained 
almost constant indicating 
the value of approximate-
ly 40% . No specific 
rleation between age and 
incidence of sex chroma-
tin was noted in the 
follicular epithelial cells 
or tumor cells as well 
as in the interstitial cells 
of benign thyroid diseas-
es. Anyhow, the inciden-
ce `of sex chromatin in 
the follicular epithelial 
cells and the interstitial
cells of benign thyroid diseases was over 30% in most of the cases. 
(Table 1, Fig. 2) 
   In 60 cases of so-called "malignant adenoma of the thyroid" which 
was diagnosed because of the evidence of capsular invasion, the 
incidence of sex chromatin in the follicular epithelial cells of seeming-
ly normal parts outside the capsule showed the mean value of 48% 
ranging from 30% to 67%. 
   The incidence of sex chromatin in the tumor cells of the region 
without capsular invasion within so-called malignant adenoma of the 
thyroid was 37% in mean value ranging from 20% to 58%. There
Photo. 1 This picture shows a capsular invasion (arrow) of 
           so-called Maliguant Adenoma. (x 100. H-E stain)
Photo. 3 Sex Chromatin is seldom seen in the nuclei of papillary adenocarcinoma 
          cells of thyroid gland (X1400. Feulgen s stain)
were only 9 cases out of 60 that showed the value less than 30% . 
The incidence in the tumor cells with capsular invasion in the cases 
of so-called malignant adenoma of the thyroid ranged widely from 11% 
to 68'% but the incidence less than 30% was noted in 39 cases out of
60 or in 2/3 of the cases, 
The difference in inci-
dence of sex chromatin 
among three regions in 
the follicular epithelial 
cells of so-called malignant 
adenoma was significant. 
The incidence was lower 
in the region of malig-
nant adenoma than in the 
seemingly normal region. 
Within the regions of 
malignant adenoma, the 
incidence was the lowest 
in the region of capsular 
invasion. (Fig. 5, 6 ) 
(Photo. 1) 
   For calculation of sex 
chromatins in the cases 
of thyroid cancer, which 
was classified by UICC 
(International Union 
against Cancer) classifica-
tion into papillary adeno-
carcinoma, follicular ade-
nocarcinoma and undiffe-
rentiated carcinoma, sex 
chromatins were counted 
in cancer cells and inter-
stitial cells respectively. 
Sex chromatins were also 
counted in the follicular 
epithelial cells of normal 
regions without cancer 
invasion. For the cases 
of metastasized thyroid 
cancer, calculation of sex 
chromatins was made in 
the primary lesions and 
metastasized lesion in the 
lymph nodes and the
Fig. 7 Incidence of Sex Chromati in 
        Thyroid Cancer
1: Cancer Cells 
2:Interstitial Cells 
3 : Follicular Epithelial 
 Cells outside Thyroid 
  Cancer
incidence in the two lesions were compared. 
   The incidence of sex chromatin in the cancer cells in 63 cases of 
papillary adenocarcinoma was 19% in mean ranging from 5% to 32%. 
The incidence in the cancer cells in 49 cases of follicular adenocarcino-
ma ranged from 10% to 42% with the mean of 22% which was some-
what lower than that in the cases of papillary adenocarcinoma. 
However, there was no significant difference (P=0.05) between two
Fig. 8. Incidence of Sex Chromatin in 
         Occult Sclerosing Carcinoma 
         Present in Diffuse Coiter with 
        Hyperthyroidism
Eig. 9. Incidence of Sex Chromat in 
        Metstasized Carcinoma to
        Lymph Node (60 Cases)
1: Cancer Cells 
2 : Hyperfunctional Follicular 
 Epithelial Cells Surrounding 
  the Cancer
1: Primary Lesion 
2 : Nodal Metastasis
groups. (Photo. 3) 
   In the 8 cases of undifferentiated carcinoma of the thyroid, the 
incidence was from 10% to 20% with the mean of 15%. This value 
in the undifferentiated cases was lower as compared with that in the 
differentiated cases of papillary and follicular adenocarcinomas. 
(Table 2) 
   The incidence of sex chromatin in the interstitial cells in the total 
cases of thyroid cancer ranged from 20% to 61% with the mean of 
37%. The incidence in the follicular epithelial cells of normal region 
without invasion of thyroid cancer ranged from 26% to 58% with the 
mean of 45%. (Fig. 7) 
   For the 19 cases of occult sclerosing carcinoma of the thyroid 
accompanied by BASEDOw's disease, the incidence in the cancer cells 
ranged from 11% to 37% with the mean of 21% and that in the 
hyperfunctioned follicular epithelial cells surrounding the concer ranged 
from 39% to 62% with the mean of 51%. The difference between the 
two incidences was significant, the former being lower. (Fig. 8) 
   For the 56 cases of metastasized thyroid cancer to the lymph 
nodes, the incidence of sex chromatin in the primary lesion was 
compared with that in the metastasized lesion. The former ranged 
from 4% to 37% with the mean of 21% and the latter ranged from 2% 
to 36% with the mean of 18%. There was no significant difference 
(P=0.05) between the two. (Fig. 9) 
   Upon classifying thyroid cancer into papillary adenocarcinoma, 
follicular adenocarcinoma and undifferentiated carcinoma according to 
the UICC classification of thyroid cancer tissue, the incidence of sex 
chromatin was compared among these groups. Of the three, undiffe-
rentiated carcinoma showed evidently lower value than papillary and 
follicular adenocarcinomas which are differentiated carcinomas. There 
was no significant difference in incidence of sex chromatin between 
the primary lesion and the metastasized lesion. 
   In the cases of occult sclerosing carcinoma of the thyroid occur-
ring in diffuse goiter with hyperthyroidism, the incedence of sex 
chromatin was high in the region of hyperfunction without carcinoma 
and markedly low in the region of carcinoma as compared witn the 
former . 
                   DISCUSSION 
   Sex chromatin was first discovered by BARRu in 1949 and since 
then it has been used for the determination of sex in genetics. 
Concerning the origin of sex chromatin, MOORE, GRAHAM and BARR13) 
described that the two X chromosomes in the cell or static nucleus are 
fused mutually at the heterochromatic region and sex chromatin is
dense and large in females because of the presence of XX but is 
hardly recognized in males because of the presence of only one X 
chromosome. 
    On the other hand, ON019) and STEWART23) explained thet one of 
the two X chromosomes is metabolically active and enlarged so as not 
to be recognizable but the other one is in pause and entirely condensed 
to form a sex chromatin. This theory is in compliance with the 
report of JACOBS10) and others that the number of sex chromatins is 
always one less than that of sex chromosomes with two or more X 
chromosomes. 
    DAVIDSON and SMITH°U) recognized sex chromatin or "Dramstick" in 
neutrophile leucocyte and reported that the incidence was 2-3% in 
females and nearly zero in mals. 
    As to the incidence of sex chromatin in various normal tissues of 
man, it has been reported to be 62-82% in females and 2-21% in 
males by MOORE and BARR2); 13-39% in females and 0-4% in males 
by GRAF and MAZOLI6); 0-9% in males but 0-5% in the overwhelming 
majority of males and 25-54% in females by EMERY and MCMILLAN5). 
RODERMUND21) reported the incidence to be 29-50% in females and 
mean of 10% in males with no case over 20%. TAYLOR26) reported 
that incidence of sex chromatin in female infants was 10-20% being 
lower than that in adults; EMERY5) reported that there was no differen-
ce in incidence of sex chromatin between infants and adults. 
   At present, there is no adequate explanation for the fact that the 
incidence of sex chromatin in females is actually less than 100% while 
it should be 100% theoretically. This may be due to various factors 
such as staining, thickness of section, different distribution of sex 
chromatins within the nucleus, various stages of mitosis and chromo-
some aberrations. 
   Specimens were stained by FEULGEN'S method. Since this method 
is generally difficult, the stained specimens may be considered satis-
factory as long as sex chromatins in the interstitial cells are countable. 
However, if it is difficult to count the sex chromatins in any specimen 
due to unsatisfactory staining, the specimen should be excluded from 
calculation and should be restained. 
   The specimens of thyroid cancer showed poor reaction to Feulgen's 
stain often requiring restaining. Those of undifferentiated carcinoma 
generally showed satisfactory staining. 
   JAMES11) found nucleoli (sex chromatins) larger than other nucleoli 
in 70-80% of cell nuclei and stated that those nucleoli attached to the 
nuclear membrane are the typical sex chromatins which occupy 51% 
and free nucleoli within the nuclear substance occupy as much as 
28% . 
   MYERS17) reported that sex chromatins attached to the nuclear 
membrane were found in 50 out of 61 fibroblasts and those free within
the nuclear substance or adjacent to the karyosome were quite rare 
and difficult to distinguish from other nucleoli, and hence these were 
not actually, counted. For the same reason, the author also excluded 
these free sex chromatins from calculation and counted only those 
typical ones attached to the nuclear membrane. 
    JAMES11) confirmed that, in the process of mytosis, sex chromatin 
is recognized up to the prophase but disappears in the metaphase and 
appears again in the telephase. 
   The incidence of sex chromatin may vary by the thickness of 
histological specimen ...... if the specimen is too thick, cells will be 
overlapped and sex chromatins will not be clearly seen ; and if the 
specimen is too thin, the number of sex chromatins to be counted will 
be small. Hence it is necessary to prepare all specimens at the same 
thickness. In the present study, the thickness was maintained to be 
6a. 
   With the smears of exforiative cells of the oral mucous membrane 
which require no consideration of the thickness of section, the values 
of the incidence of sex chromatin should be more accurate than those 
with the other specimens mentioned above. However, even with the 
smears of the oral mucous membrane, the incidence of sex chromatin 
in the cells of females has been reported to be 40 - 60% by Moore and 
BARR13) and 20-79% by NELSON18). Thus, there seems to be some 
factor which causes the incidence in females to be less than 100% 
irrespective of the thickness of section. 
   Some reports indicated that the incidence of sex chromatin varies 
by menstrual cycle and administration of antibiotics. 
   In 1954, HUNTER and LENNOX9) reported that the incidence of sex 
chromatin in the 12 female cases of teratoma showed as high value as 
that in normal females; and that 4 out of the 9 male cases of teratoma 
showed low value of 0-5% which is identical to the value in normal 
males but 5 other cases were of female type, thus indicating discre-
pancy in sex between the host and tumor cells. This report was 
followed by the studies on sex chromatin of tumors by TAVARES25), 
BARR and MOORE13. Subsequently, studies were made on sex chromatin 
in prostate hypertrophy and mammary cancer and sex chromatin has 
been examined as the index of hormone dependency and hormone 
therapy of mammary cancer. At present it is still unknown as to 
under what condition of tumor particularly of cancer cells the inciden-
ce of sex chromatin decreases. However, direct effect of sex hormone 
on cancer cells, and quantitative and qualitative aberration of chromo-
somes in the tumor cell nucleus are considered as big factors causing 
decreased incidence of sex chromatin in cancer cells. 
   It has also been reported by HIENZ and EHLER8), WANKE, GRAF and 
MAZOLI27), MYERS17), and HARADA7j that the incidence of sex chromatin 
in mammary cancer is related to the degree of morphological differen-
tiation and moreover, even within the same type of tissue, low inci-
dence of sex chromatin results in poor prognosis but high incidence 
generally results in good prognosis. Thus, the incidence of sex 
chromatin in cancer cells was studied in relation to the degree of 
histological differentiation and further to the degree of functional 
differentiation, and it has been considered to be available as a means 
to estimate the degree of the dependency of cancer cells on hormone. 
    From this point of view, the author carried out a survey on the 
incidence of sex chromatin in tumors which frequently occur in the 
thyroid of females. The normal thyroid specimens used in the present 
study were those obtained mostly by incisional biopsy from the 
patients who visited the hospitals with some complaint but whose 
histological examination revealed no abnormality. The incidence of 
sex chromatin in the follicular epithelial cells of normal thyroid was 
50% in mean indicating a higher value than that in the cases of benign 
thyroid diseases: 45% in diffuse goiter with hyperthyroidism, 44% in 
adenoma and 41% in adenomatous goiter. However, no significant 
difference (P=0.05) was noted among all these groups. 
   As to the relationship between the incidence of sex chromatin in 
the follicular epithelial cells (or tumor cells) and age, the mean value 
under age 19 was 61% and gradually decreased along with the advance-
ment of age marking approximately 40% over age 40. In the cases of 
benign or malignant thyroid diseases other than normal thyroid, there 
was no specific relationship between the incidence of sex chromatin 
and age. 
   In the interstitial cells, survey on the incidence of sex chromatin 
was made mostly for f ibroblast and f ibrocyte . The mean values were 
39% in normal thyroid, 39.9% in diffuse goiter with hyperthyroidism, 
39.1% in adenoma, and 37.1% in cancer. Though the last value was 
somewhat lower than the others, there was no significant difference 
among these various groups. 
   Adenoma was diagnosed to be malignant when pathological exami-
nation revealed capsular invasion. For these cases, the incidence of 
sex chromatin was calculated in the region of copsular invasion but 
not in the region of vascular invasion nor in the region of metastasis 
to the lymph nodes. In the region of capsular invasion in malignant 
adenoma, the value was as low as 30% or less in 2/3 of the cases. 
   In the cases of thyroid cancer, the incidence of sex chromatin was 
21% in mean. Of the 120 cases, only 7 cases consisting of 3 follicular 
type cases and 4 papillary type cases indicated the incidence over 30%. 
In other words, the incidence of sex chromatin in cancer cells in 
most of the cases of thyroid cancer is under 30% being remarkably 
low as compared with the value for adenoma. The value of 30% 
being the border, most of the cases of bening adenoma indicate values 
over 30% and most of the cases of cancer indicate values under 30%.
                   CONCLUSION 
   The incidence of sex chromatin in thyroid tissues in various con-
ditions showed histological relationship to, the degree of morphological 
differentiation. It was over 30% in benign thyroid diseases and under 
30% in malignant diseases. 
   The incidence of sex chromatin in thyroid diseases may be an 
auxiliary guide to classify the diseases and may also be used for the 
determination of prognosis. 
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